MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-20-0012747
Snehal Pharma & Surgicals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹20.74 Cr
▼ 25% YoY
Net loss · FY 2024
₹4.63 Cr
Net margin -22.3%
EBITDA · FY 2024
₹2.53 Cr
EBITDA margin 12.2%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹7.29 Cr
Issued & subscribed
Open charges
₹50.96 Cr
Satisfied ₹15.82 Cr
Company age
15 yrs
Est. 2011
Employees · EPFO
38
Provident fund records
About Snehal Pharma & Surgicals Private Limited
Data last updated:
Snehal Pharma & Surgicals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 June 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33110MH2011PTC218317. Its GSTIN is 27AAPCS8743Q1Z6 (Maharashtra).
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹7.29 Cr. It is led by directors Sudhir Ravindra Deulgaonkar (Managing Director) and Subodh Ravindra Deulgaonkar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at E – 101 Floor – 1st Plot No. 163E Vasant Kunj Dr. Babasaheb Ambedkar Road Dadar(E), Mumbai, Maharashtra, India – 400014.
As per the financials filed for FY 2024, the company reported a revenue of ₹20.74 Cr, a decline of 25% compared to the previous year. For the same year it recorded a net loss of ₹4.63 Cr (net margin -22.3%) and EBITDA of ₹2.53 Cr (EBITDA margin 12.2%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 15% over five years.
The company has about 38 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Snehal Pharma. As per MCA filings, the company has open charges of ₹50.96 Cr and satisfied charges of ₹15.82 Cr on record. Court records list 3 cases involving the company, including 3 filed against it; 1 case is pending. The company has 6 deals on record (3 funding rounds, 2 rights issues, 1 secondary share transfer), with disclosed funding of ₹5.34 Cr; the latest was in March 2021. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 5 smaller; the largest is Macsur Pharmaa (India) Private Limited with revenue of ₹20.84 Cr.
Snehal Pharma & Surgicals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-20-0012747). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website snehalpharma.in.
Company details
CIN U33110MH2011PTC218317
Registration Number 218317
Incorporation Date 06 June 2011
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-20-0012747
Recognitions & Rankings of Snehal Pharma & Surgicals
Contact details
Snehal Pharma & Surgicals Private Limited's registered office is in Mumbai, Maharashtra. Its website is snehalpharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressE – 101 Floor – 1st Plot No. 163E Vasant Kunj Dr. Babasaheb Ambedkar Road Dadar(E), Mumbai, Maharashtra, India – 400014
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Snehal Pharma & Surgicals Private Limited, buy the company report.
Comprehensive company report
Snehal Pharma & Surgicals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Snehal Pharma & Surgicals operates one associated brand: Snehal Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulation manufacturing and distribution in Nagpur, India. | snehalpharma.in |
Business activity
The main business activity of Snehal Pharma & Surgicals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Snehal Pharma & Surgicals Private Limited, buy the company report.
Financials of Snehal Pharma & Surgicals Private Limited
FY 2024 filings availableSnehal Pharma & Surgicals Private Limited reported revenue of ₹20.74 Cr (down 25% YoY) for FY 2024.
Revenue · FY 2024
₹20.74 Cr ▼ 25%
Net loss · FY 2024
₹4.63 Cr margin -22.3%
EBITDA · FY 2024
₹2.53 Cr margin 12.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 25%
3 years · compounded
▼ 1%
5 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▼ 68%
3 years · compounded
▲ 33%
5 years · compounded
▲ 22%
Revenue fell 25% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 15%. EBITDA fell 68% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.53 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.63 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.2% | ||||
| Net Profit Margin | -22.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Snehal Pharma & Surgicals Private Limited, buy the company report.
Board of directors of Snehal Pharma & Surgicals Private Limited
Snehal Pharma & Surgicals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudhir Ravindra Deulgaonkar Also directs: Snehal International Pharma Private Limited | Managing Director | 06 Jun 2011 | 15 Years 4 Months | Current |
| Subodh Ravindra Deulgaonkar Also directs: Snehal Labs Private Limited, Mas Infraway Private Limited | Director | 06 Jun 2011 | 15 Years 4 Months | Current |
Peer comparison
Snehal Pharma & Surgicals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Macsur Pharmaa (India) Private Limited | ₹20.84 Cr (FY 2024) | 5.0% | Puduchery, Puducherry, India | |||
| Maple Biotech Pvt Ltd | ₹20.82 Cr (FY 2024) | 3.0% | Pune, Maharashtra, India | |||
| Snehal Pharma & Surgicals Private Limitedthis company | ₹20.74 Cr (FY 2024) | -₹4.63 Cr | -22.3% | -25.0% | 38 | Mumbai, Maharashtra, India |
| Sheetal Chemicals Private Limited | ₹20.73 Cr (FY 2025) | 119.0% | Hyderabad, Telangana, India | |||
| Instant Remedies Private Limited | ₹20.64 Cr (FY 2025) | -7.0% | Chandigarh, India | |||
| Kesar Pharma Limited | ₹20.63 Cr (FY 2025) | -26.0% | Gandhinagar, Gujarat, India | |||
| Dewcare Concept Private Limited | ₹20.61 Cr (FY 2025) | 2.0% | Ahmedabad, Gujarat, India | |||
| Bda Health Care Private Limited | ₹20.61 Cr (FY 2025) | 1.0% | Parshivani, Maharashtra, India |
To see the full peer comparison of Snehal Pharma & Surgicals Private Limited, buy the company report.
Auditor
Snehal Pharma & Surgicals Private Limited is audited by Mahesh Ladvikar & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Mahesh Ladvikar & Co. | FY 2023 | 142491W |
Shareholding
The shareholding of Snehal Pharma & Surgicals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Snehal Pharma & Surgicals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹50.96 Cr
Satisfied charges
₹15.82 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Mar 2020 | 100334191 | Nagpur Nagarik Sahakari Bank Limited | ₹26.6 Cr | Open | |
| 01 Oct 2018 | 100222296 | Nagpur Nagarik Sahakari Bank Limited | ₹17.5 Cr | Open | |
| 13 May 2016 | 100032603 | Nagpur Nagarik Sahakari Bank Limited | ₹6.86 Cr | Open | |
| 26 Sep 2020 | 100370949 | Nagpur Nagarik Sahakari Bank Limited | ₹50 Lakh | Satisfied | |
| 29 Jul 2020 | 100353732 | Sidbi | ₹50 Lakh | Satisfied |
To see the full charge records of Snehal Pharma & Surgicals Private Limited, buy the company report.
Total charge records: 10 View all charges
Deals & funding
Snehal Pharma & Surgicals Private Limited has 6 deals on record (3 funding rounds, 2 rights issues, 1 secondary share transfer), with disclosed funding of ₹5.34 Cr; the latest was in March 2021.
Total deals
6
Funding rounds
3
Rights issues
2
Secondary share transfer
1
Disclosed funding
₹5.34 Cr
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Mass Infraway Private Limited |
| Nov 2019 | Funding round | ₹2.54 Cr | Investors: Mass Infraway Private Limited, Subodh Ravindra Deulgaonkar HUF, 2 individuals |
| Dec 2017 | Funding round | ₹2.35 Cr | Investors: Mass Infraway Private Limited, 3 individuals |
| Mar 2016 | Rights issue | ₹1.57 Cr | Investors: 4 individuals |
| May 2014 | Rights issue | ₹33.7 Lakh | Investors: an individual |
To see the full deal history of Snehal Pharma & Surgicals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Snehal Pharma & Surgicals Private Limited has 3 court cases on record: 3 filed against it. 1 case is pending and 2 are disposed.
Total cases
3
Filed against the company
3
Pending
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Cheque dishonour complaint | Filed against the company by Om Logistics Ltd | Disposed |
| District court, South Goa, Goa | Court case (AOA) | Filed against the company by Union of India, Rep. by Drugs Inspector | Pending |
| District court, South Goa, Goa | Court case (AOA) | Filed against the company by Union of India, Cdsco, Rep. by Drugs Inspector - Shivaji Sulgudle | Disposed |
To see the full case history of Snehal Pharma & Surgicals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Snehal Pharma & Surgicals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Snehal Pharma & Surgicals Private Limited has a workforce of 38 employees on its EPFO records as of Mar 31, 2024, across 1 active EPFO establishment.
Employee count
38
Active EPFO establishments
1
Employee growth
-7.32%
GST
Snehal Pharma & Surgicals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAPCS8743Q1Z6 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Snehal Pharma & Surgicals Private Limited, buy the company report.
Recent activity
Snehal Pharma & Surgicals Private Limited has 4 board changes on record since 2011: 2 appointments and 2 cessations. The latest: Anita Sudhir Deulgaonkar ceased to be Director on 04 Feb 2021.
AGM
Snehal Pharma & Surgicals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Snehal Pharma & Surgicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge registered on 29 Jul 2020 via Charge ID 100353732 with Sidbi was fully satisfied on 01 Aug 2022.
Charges
A charge registered on 26 Sep 2020 via Charge ID 100370949 with Nagpur Nagarik Sahakari Bank Limited was fully satisfied on 30 May 2022.
Charges
A charge with Nagpur Nagarik Sahakari Bank Limited of Rs. 26.60 Cr registered on 23 Mar 2020 with Charge ID 100334191 was modified on 03 Dec 2021.
Ceased
Anita Sudhir Deulgaonkar ceased to be Director.
Charges
A charge with Nagpur Nagarik Sahakari Bank Limited amounted to Rs. 0.50 Cr with Charge ID 100370949 was registered on 26 Sep 2020.
Charges
A charge with Sidbi amounted to Rs. 0.50 Cr with Charge ID 100353732 was registered on 29 Jul 2020.
Charges
A charge with Nagpur Nagarik Sahakari Bank Limited amounted to Rs. 26.60 Cr with Charge ID 100334191 was registered on 23 Mar 2020.
Charges
A charge registered on 20 Mar 2017 via Charge ID 100109682 with Others was fully satisfied on 29 Apr 2019.
Charges
A charge registered on 07 May 2016 via Charge ID 100032594 with Others was fully satisfied on 29 Apr 2019.
Charges
A charge registered on 07 May 2016 via Charge ID 100032581 with Others was fully satisfied on 29 Apr 2019.
15 earlier events are in the company report.
Frequently asked questions
Snehal Pharma & Surgicals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 June 2011 (15+ years old) and is registered under CIN U33110MH2011PTC218317.
Snehal Pharma & Surgicals has 2 current directors:
- Sudhir Ravindra Deulgaonkar - Managing Director
- Subodh Ravindra Deulgaonkar - Director
The latest financial statements of Snehal Pharma & Surgicals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Snehal Pharma & Surgicals is 27AAPCS8743Q1Z6, registered in Maharashtra.
The CIN (Corporate Identification Number) of Snehal Pharma & Surgicals is U33110MH2011PTC218317. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Snehal Pharma & Surgicals has 3 court cases on record: 3 filed against it. 1 is pending.
Snehal Pharma & Surgicals was incorporated on 06 June 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
Snehal Pharma & Surgicals has 6 deals on record (3 funding rounds, 2 rights issues, 1 secondary share transfer), with disclosed funding of ₹5.34 Cr; the latest was in March 2021.
The peers of Snehal Pharma & Surgicals by revenue are Macsur Pharmaa (India) Private Limited, Maple Biotech Pvt Ltd, Sheetal Chemicals Private Limited, Instant Remedies Private Limited, Kesar Pharma Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anita Sudhir Deulgaonkar ceased to be Director on 04 Feb 2021. Charudatta Dinkar Bokare ceased to be Director on 11 Dec 2015. Subodh Ravindra Deulgaonkar was appointed as Director on 06 Jun 2011. Snehal Pharma & Surgicals has 4 board changes on record in total.
Yes, Snehal Pharma & Surgicals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-20-0012747).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages